(Q57560381)

Silvia Franceschi

4

0 references

Carlo La Vecchia

Carlo La Vecchia

9

0 references

Eva Negri

2

Eva Negri

0 references

Valerie Beral

5

Valerie Beral

0 references

Dimitris Trichopoulos

3

Dimitrios Trichopoulos

0 references

Cristina Bosetti

1

Cristina Bosetti

0 references

Stefano Greggi

8

Stefano Greggi

0 references

Anastasia Tzonou

6

International Journal of Cancer

Anastasia Tzonou

0 references

language of work or name

English

0 references

publication date

22 October 2002

0 references

published in

0 references

volume

102

0 references

page(s)

262-265

0 references

issue

3

0 references

cites work

The epidemiology of ovarian cancer

1 reference

Oral contraceptives and cancer: an update

21 January 2018

1 reference

Cancer mortality in Europe: effects of age, cohort of birth and period of death.

21 January 2018

1 reference

Cancer mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994

21 January 2018

1 reference

Factors affecting the association of oral contraceptives and ovarian cancer.

21 January 2018

1 reference

Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.

21 January 2018

1 reference

A case-control study of oral contraceptive use and invasive epithelial ovarian cancer

21 January 2018

1 reference

Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study

21 January 2018

1 reference

Risk factors for ovarian cancer: a case-control study

21 January 2018

1 reference

Estrogen replacement therapy and ovarian cancer risk

21 January 2018

1 reference

Reproductive and hormonal factors and ovarian cancer.

21 January 2018

1 reference

Risk Factors for Ovarian Cancer in Central Italy

21 January 2018

1 reference

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

21 January 2018

1 reference

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

Parity, contraception, infertility, and the risk of epithelial ovarian cancer

21 January 2018

1 reference

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

21 January 2018

1 reference

Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use

21 January 2018

1 reference

The reduction in risk of ovarian cancer associated with oral-contraceptive use

21 January 2018

1 reference

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

21 January 2018

1 reference

Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions

21 January 2018

1 reference

The epidemiology of ovarian cancer in Greece: a case-control study

21 January 2018

1 reference

Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer

21 January 2018

1 reference

Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer

21 January 2018

1 reference

21 January 2018

1 reference